Clinician's Roundtable Targeting Individualized Cancer Treatment
May 15, 2008
00:00
Host: Bruce Bloom, DDS, JD
Guest: Walter Stadler, MD
Targeted and Individualized Therapies for Cancer. Where are we? What's on the horizon? Associate Dean of Clinical Research, Professor of Medicine and Director of the Genitourinary program at the University of Chicago Pritzker School of Medicine, Dr. Walter Stadler, cites the majority of patients struggling with the side effects - while grasping for the benefits - of cancer therapy as a necessity for individualized therapy. Dr. Stadler and Dr. Bloom discuss individualized treatment as a reality via biomarker identification, and management of cancer heterogeneity of various cancers within the same patient.
Guest: Walter Stadler, MD
Targeted and Individualized Therapies for Cancer. Where are we? What's on the horizon? Associate Dean of Clinical Research, Professor of Medicine and Director of the Genitourinary program at the University of Chicago Pritzker School of Medicine, Dr. Walter Stadler, cites the majority of patients struggling with the side effects - while grasping for the benefits - of cancer therapy as a necessity for individualized therapy. Dr. Stadler and Dr. Bloom discuss individualized treatment as a reality via biomarker identification, and management of cancer heterogeneity of various cancers within the same patient.